Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | Tibremciclib |
Synonyms | |
Therapy Description |
Tibremciclib inhibits CDK4/6, potentially resulting in antitumor activity (Ann Oncol (2024) 35 (suppl_2): S349). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
Tibremciclib | BPI-16350|BPI16350|BPI 16350 | CDK4/6 Inhibitor 14 | Tibremciclib inhibits CDK4/6, potentially resulting in antitumor activity (Ann Oncol (2024) 35 (suppl_2): S349). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|